This project seeks to develop new methods for imaging oxidative and vascular function in the brain. The methods under development are based on widely available MRI hardware, which will make them feasible for use in future clinical drug trials, an application that is of interest to the partner organization CQDM. Before the approach is ready for commercial application, a number of methodological issues must be addressed to achieve optimal sensitivity, specificity, and tolerability in patients.